Grace Akinyele

Grace is developing a bioengineered platform to preserve mitochondrial viability and function for extended periods outside living organisms. Her platform will enable the use of frozen mitochondrial samples, addressing current limitations in studying mitochondrial dysfunction. This approach supports more practical and scalable research into Alzheimer’s disease, where defects in mitochondrial function play a central role. Grace is completing her PhD in Molecular Pharmacology at the University of Pittsburgh.